Childhood cancer treatments can accelerate biological aging which increases survivors’ risk for long-term health issues like ...

The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced the 2025 class of the Pew-Stewart Scholars Program for Cancer Research.

U.K. woman Lara Muller was diagnosed with Hodgkin lymphoma after initially being told her symptoms were due to her job and ...

Three new treatments for cancer have been approved for use by the NHS in Scotland. The Scottish Medicines Consortium (SMC) ...

Medically reviewed by Archana Sharma, DO You might know that finding a lump in your breast means you should have it looked at. But lumps are not the only possible signs of cancer. Lesser-known ...

Adults with Sjögren’s disease complicated by a subtype of cutaneous vasculitis are more likely to develop non-Hodgkin’s ...

Casey Cattie visited several doctors to understand why her ring reported frequent fevers. A health emergency finally helped ...

The FDA accepted a supplemental application for Breyanzi to treat adults with relapsed or refractory marginal zone lymphoma ...

US FDA accepts for priority review Bristol Myers Squibb’s sBLA for Breyanzi to treat adult patients with relapsed or refractory MZL: Princeton, New Jersey Wednesday, August 6, 2 ...

Based on positive Phase II TRANSCEND FL data showing a 95.5% overall response rate, the FDA has accepted Bristol Myers Squibb’s sBLA for Breyanzi in relapsed or refractory MZL with a PDUFA date set ...

FDA prioritizes review of liso-cel, a groundbreaking CAR T-cell therapy for relapsed marginal zone lymphoma, promising ...

Delayed treatments, canceled doctor visits, skipped prescriptions. Losing insurance is bad for your health. The Congressional ...